MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

CUSIP: 590328AA8

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Debt / NOTE 4.500% 7/1
Market price (% of par)
74.48%
Total 13F principal
$52,419,000
Principal change
$0
Total reported market value
$38,302,000
Number of holders
9

Quarterly Holders Quick Answers

What is CUSIP 590328AA8?
CUSIP 590328AA8 identifies 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q2 2017

As of 30 Jun 2017, MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 was held by 9 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $52,419,000 in principal (par value) of the bond. The largest 9 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, PUTNAM INVESTMENTS LLC, JPMORGAN CHASE & CO, PALISADE CAPITAL MANAGEMENT LLC/NJ, Jefferies Group LLC, and WELLS FARGO & COMPANY/MN. This page lists 9 institutional bondholders reporting positions for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.